Lupin Pharmaceuticals Inc. has recalled 11,609 cartons of Bekyree (desogestrel and ethinyl estradiol) and Levonorgestrel and Ethinyl Estradiol tablets due to testing results that showed inconsistent levels of the active drug ingredients. This recall includes 1,712 cartons of Bekyree and 9,897 cartons of Levonorgestrel and Ethinyl Estradiol combination tablets. These prescription birth control medications were distributed nationwide across the United States and Puerto Rico. Consumers are advised to consult their healthcare provider regarding these specific lots as the product may not contain the correct medication dosage required for effectiveness.
The recalled tablets failed content and blend uniformity tests, meaning the active ingredients may not be distributed evenly across the tablets. This could result in a consumer receiving a dose that is either too low, potentially leading to unintended pregnancy, or too high, increasing the risk of side effects.
Product return and refund through healthcare channels.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.